dimyristoylphosphatidylcholine has been researched along with Bone Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, K; Ichihara, H; Kitajima, H; Komizu, Y; Ueoka, R | 1 |
| Cabanillas, F; Glenn, H; Haynie, T; Hersh, EM; Jahns, M; Kasi, LP; Lopez-Berestein, G; Perez-Soler, R | 1 |
2 other study(ies) available for dimyristoylphosphatidylcholine and Bone Cancer
| Article | Year |
|---|---|
Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
Topics: Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Dimyristoylphosphatidylcholine; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Osteosarcoma; Polidocanol; Polyethylene Glycols; Random Allocation | 2013 |
Distribution of technetium-99m-labeled multilamellar liposomes in patients with Hodgkin's disease.
Topics: Adult; Bone Neoplasms; Dimyristoylphosphatidylcholine; Female; Hodgkin Disease; Humans; Liposomes; Liver Neoplasms; Male; Middle Aged; Phosphatidylglycerols; Radionuclide Imaging; Splenic Neoplasms; Technetium; Time Factors; Tissue Distribution; Whole-Body Counting | 1985 |